SearchDictionaryMobileLogin Register FREE

Double Outlet Right Ventricle

97  relevant articles (2 outcomes, 4 trials/studies) found for this Disease

Description: Incomplete transposition of the great vessels in which both the AORTA and the PULMONARY ARTERY arise from the RIGHT VENTRICLE. The only outlet of the LEFT VENTRICLE is a large ventricular septal defect (VENTRICULAR SEPTAL DEFECTS or VSD). The various subtypes are classified by the location of the septal defect, such as subaortic, subpulmonary, or noncommitted.

Also Known As:
Double Outlet Right Ventricle, Noncommitted VSD; Double Outlet Right Ventricle, Subaortic VSD; Double Outlet Right Ventricle, Subpulmonary VSD; Anomaly, Taussig-Bing; Taussig Bing Anomaly; Taussig-Bing Anomaly

Relationship Network

Disease Context: Research Results

Related Diseases

1. Pulmonary Valve Stenosis (Pulmonary Stenosis)
2. Ventricular Heart Septal Defects (Ventricular Septal Defect)
3. Tetralogy of Fallot (Fallot Tetralogy)
4. Pulmonary Atresia (Pulmonary Valve Atresia)
5. Tricuspid Atresia
35 Diseases and 65 more articles analyzed in the Research Interface, order at left...

Experts

1. Bernstein, Jonathan: 1 article (07/2008)
2. Collazos, Juan C: 1 article (07/2008)
3. Ciccolo, Michael L: 1 article (07/2008)
4. Evans, William N: 1 article (07/2008)
5. Winters, James M: 1 article (07/2008)
6. Krueger, Justin: 1 article (07/2008)
7. Restrepo, Humberto: 1 article (07/2008)
8. Acherman, Ruben J: 1 article (07/2008)
9. Kamata, Kotoe: 1 article (01/2006)
10. Nagata, Osamu: 1 article (01/2006)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Double Outlet Right Ventricle:
1. Staphylococcal Protein A (A, Protein)IBA
2. tranilast (N 5')IBA
01/01/1984 - "Complicated" VSD in terms of muscular/multiple (n = 6), subaortic type of double-outlet right ventricle (n = 5), AV-canal type (n = 2) and straddling chordae (n = 2) was present in 15 cases"
02/01/1994 - "Associated cardiac lesions included double-inlet left ventricle anatomy (n = 5), double-outlet right ventricle (n = 4), abnormal aortic valve (n = 5), unbalanced atrioventricular canal (n = 3), and membranous ventricular septal defect (n = 1)"
10/01/1993 - "The primary diagnoses were transposition of the great arteries with ventricular septal defect (n = 10), transposition of the great arteries with intact ventricular septum (n = 5), Taussig-Bing anomaly (n = 4), and atrioventricular and ventriculoarterial discordance (n = 5)"
12/01/2001 - "RESULTS: Nine patients older than 30 days (median age 67 days, range 36 to 108 days) with diagnoses of hypoplastic left heart syndrome (n = 5), double-outlet right ventricle with hypoplastic aortic arch (n = 2), unbalanced atrioventricular septal defect (n = 1), or single left ventricle with subaortic stenosis (n = 1) underwent surgical palliation"
02/01/2000 - "Sixty three patients had other lesions: hypoplastic left ventricle with ventricular septal defect (n = 18), unbalanced complete atrioventricular canal (n = 9), complex double-outlet right ventricle (n = 14), double-inlet left ventricle (n = 11), tricuspid atresia with transposition of the great arteries (n = 6), and others (n = 5), including heterotaxia"
Get all the results and reference details, order at left...
3. Tretinoin (Retinoic Acid)FDA LinkGeneric
4. Myosin Type IIIBA
5. AntibodiesIBA
6. Polyethylene Terephthalates (Polyethylene Terephthalate)IBA
09/01/1975 - "Subsequently a transverse right ventriculotomy, either alone or combined with a right ventricular outflow and/or pulmonary artery patch enlargement was performed in 16 patients, and a double outlet right ventricle was created through insertion of a Dacron tube graft in two patients"
02/01/1976 - "A 41/2-year-old child developed a severe degree of intravascular hemolysis within 24 hours after intraventricular correction of double-outlet right ventricle with a Dacron patch"
06/01/1990 - "The hypoplastic left ventricle of an 11-year-old girl with complex double-outlet right ventricle was successfully incorporated in a modified biventricular repair by Dacron patch closure of the ventricular septal defect, diversion of venous return of the inferior vena cava to the mitral valve with an intraatrial baffle, insertion of a left ventricular apex to pulmonary artery valved aortic homograft, and diversion of residual systemic venous return directly to the lungs with a bidirectional superior vena cava to pulmonary artery shunt"
10/01/1976 - "In a case of double outlet right ventricle with d-transposition and atrioventricular concordance and a subvalvular pulmonary stenosis an intraventricular conduit with a 16 mm Dacron vascular prosthesis was used"
02/01/2000 - "Seventeen years after corrective surgery for a double outlet right ventricle and pulmonary stenosis, a 30-year-old patient was admitted for reoperation for a critical stenosis of a porcine-valved Dacron conduit between the right ventricle and pulmonary artery"
Get all the results and reference details, order at left...
7. OxygenIBA
07/01/1976 - "Thus, pulmonary arterial oxygen saturation greater than systemic arterial saturation is not reliable evidence of a Taussig-Bing anomaly"
06/01/2007 - "We report on a newborn infant with complex congenital heart disease (CHD) featuring double outlet right ventricle and hypoplastic left ventricle who had postductal oxygen saturation well above 95% and thus eluded pulse oximetry screening for CHD."
11/01/1976 - "Criteria for selection of patients with transposition of the great arteries of double outlet right ventricle who would benefit from a palliative Mustard procedure (Mustard atrial baffle without closure of the ventricular spetal defect) are: 1) severe symptoms; 2) pulmonary arteiral hypertension (75% systemic) with pulmonary vascular obstructive disease; and 3) pulmonary artieral oxygen saturation greater than systemic (ascending aorta) arterial oxygen saturation by approximately 10%."
01/01/1991 - "Cardiac catheterization in Case 1 revealed normal pulmonary artery pressure, severe subvalvular pulmonic stenosis, a double outlet right ventricle, a significant oxygen step-up at the atrial level and moderate systemic oxygen desaturation; while Case 2 disclosed pulmonary hypertension and mild systemic oxygen desaturation"
08/01/1989 - "The cardiac defects that best responded to PGE1 were pulmonary atresia with or without ventricular septal defect, Ebstein's anomaly, tricuspid atresia, pulmonic stenosis, double outlet right ventricle, and those that the arterial oxygen saturation increase was less than 10 vol"
Get all the results and reference details, order at left...
8. Fumigant 93 (D-D)IBA
9. Coenzyme A (CoA)IBA
10. CAV protocol (CHO)FDA Link
31 Drugs and Important Bio-Agents and 61 more articles analyzed in the Research Interface, order at left...

Therapies and Procedures

1. Cardiopulmonary Bypass (Heart-Lung Bypass)
2. Fontan Procedure (Fontan Operation)
3. Homologous Transplantation (Allograft)
4. Right Heart Bypass (Cavopulmonary Anastomosis)
5. Transplants (Transplant)
18 Therapies and Procedures and 45 more articles analyzed in the Research Interface, order at left...

Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License details >>
Price:$490.00 access via web interface, 1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m", 1 year subscription
Proceed to Checkout >>